Redundancy Found in Original Drug Identification Label

Published: 2004-12-07 06:58:00

Updated: 2004-12-07 06:58:00

The pharmaceutical companies expressed their concerns and difficulties in conforming to an upcoming regulation regarding each company’s original drug identification label requirement effective January 1, 2005.

One particular area of the companies’ voiced difficulties is an inevitable redunda...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK